Use of thymosin Alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma

• 1. 胸腺素α1制备用于治疗恶性黑色素瘤第Ⅳ期的药物中的用途 [P] . 中国专利： CN101466395A . 2009-06-24
• 2. microRNA序列在制备恶性黑色素瘤基因治疗药物中的用途 [P] . 中国专利： CN113230267A . 2021-08-10
• 3. Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma [P] . 美国专利： US8017129B2 . 2011-09-13

  机译： 胸腺素α1在制备用于治疗IV期恶性黑色素瘤的药物中的用途

• 4. Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma [P] . 美国专利： US8029799B2 . 2011-10-04

  机译： 胸腺素α1在制备用于治疗IV期恶性黑色素瘤的药物中的用途

• 5. USE OF THYMOSIN ALPHA 1 FOR PREPARING A MEDICAMENT FOR THE TREATMENT OF STAGE IV MALIGNANT MELANOMA [P] . 韩国专利： KR20090020646A . 2009-02-26

  机译： 胸腺素α1在制备治疗IV期恶性黑色素瘤的药物中的用途

• 1. Primary malignant melanoma of uterine cervix: a suggestion of new scheme of treatment combination [J] . Kyung-Jin Min, Yeun-Sun Kim, Jin-Hwa Hong, 中国癌症研究（英文版） . 2014,第003期
• 2. Does chemosensitivity-assay-directed therapy have an influence on the prognosis of patients with malignant melanoma stage IV? A retrospective study of 14 patients with malignant melanoma stage IV. [J] . Doerler M, Hyun J, Venten I, European journal of medical research. . 2007,第10期
• 3. 533 POSTER Autologous large multivalent immunogen vaccine for the treatment of stage IV malignant melanoma and stage IV renal cell carcinoma [J] . European Journal of Cancer Supplements . 2005,第2期
• 4. 533 POSTER Autologous large multivalent immunogen vaccine for the treatment of stage IV malignant melanoma and stage IV renal cell carcinoma [J] . European Journal of Cancer Supplements . 2005,第2期
• 5. Photothermal therapy combined with dinitrophenyl hapten for the treatment of late stage malignant melanoma [C] . Xiaosong Li, Nan Du, Haijun Li, Biophotonics and immune responses XII . 2017
• 6. Thymosin alpha(1) antagonizes induced apoptosis of thymocytes: A model to study the molecular mechanism of thymosin alpha(1) action. [D] . Baumann, Christian Andrew. 1997
• 7. Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma [O] . Svetomir N Markovic, Allan B Dietz, Carl W Greiner, 2006
• 8. Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma [O] . 2006

• 1. Treatment of Conjunctival Malignant Melanoma with Topical Interferon Alpha-2a [J] . Naser Salihu ,Belinda Pustina ,Brigita Drnovsek-Olup . 眼科学期刊（英文） . 2015,第3期
• 2. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B:A randomized controlled study [J] . Jing You ,Lin Zhuang ,Hong-Ying Cheng . 世界胃肠病学杂志：英文版 . 2006,第41期
• 3. A Randomized Controlled Clinical Study on the Treatment of Thymosin alpha-1 versus Interferon alpha for Patients with Chronic Hepatitis B Lacking HBeAg in China [J] . YOUJing ,ZHUANGLin ,CHENGHong-ying . 世界感染杂志 . 2004,第6期
• 4. Current Trends and Future Directions in Clinical Trials for Malignant Melanoma Treatment Using Anti-Angiogenic Strategies [J] . Daemon Dewing ,Rowan Pritchard Jones . 癌症治疗（英文） . 2012,第4期
• 5. 原发食道恶性黑色素瘤临床特征及治疗预后分析:17例原发食道恶性黑色素瘤病例报道 [C] . 王轩 ,斯璐 ,孔燕 . 第十五届全国临床肿瘤学大会暨2012年CSCO学术年会 . 2012
• 6. 可注射水凝胶负载药物用于黑色素瘤靶向治疗和免疫诱导 [A] . 龙帅宇 . 2020